Linked Life Data

11236312

Source:http://linkedlifedata.com/resource/pubmed/id/11236312

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2001-3-9
pubmed:abstractText
Predisposition testing (i.e., genetic testing that provides information about a person's susceptibility to disease) is now available for several inherited forms of cancer. Individuals who are found to have an altered gene (e.g., a germ-line mutation in a cancer susceptibility gene) have a higher risk of developing cancer than those who do not carry an altered gene. Therefore, predisposition testing can be a powerful clinical tool for assessing a person's risk for developing cancer. All health care providers, particularly cancer care providers, should be knowledgeable about cancer predisposition testing options. This article provides an overview of predisposition testing for inherited breast cancer, including general facts about testing, potential risks and benefits, specific genetic counseling issues, and molecular details of known breast cancer susceptibility genes.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0890-9091
pubmed:author
pubmed:issnType
Print
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1227-41; discussion 1241-2
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed:year
1998
pubmed:articleTitle
Predisposition testing for inherited breast cancer.
pubmed:affiliation
Cancer Risk Clinic, University of Chicago Medical Center, Chicago, Illinois, USA.
pubmed:publicationType
Journal Article, Review, Case Reports